Suchergebnisse - "Lavecchia, Antonio"

PubPharm (217)

81

Amorfrutins are efficient modulators of peroxisome proliferator-activated receptor gamma (PPARγ) with potent antidiabetic and anticancer properties : a patent evaluation of WO2014177593 A1

enthalten in: Expert opinion on therapeutic patents | 2015

von Lavecchia, A. | Di Giovanni, C.

82

Amorfrutins are efficient modulators of peroxisome proliferator-activated receptor gamma (PPARγ) with potent antidiabetic and anticancer properties: a patent evaluation of WO2014177593 A1

enthalten in: Expert opinion on therapeutic patents | 2015

von Lavecchia, A. | Di Giovanni, C.

83

Machine-learning approaches in drug discovery: methods and applications

enthalten in: Drug discovery today | 2015

von Lavecchia, A.

84

In silico methods to address polypharmacology: current status, applications and future perspectives

enthalten in: Drug discovery today | 2015

von Lavecchia, A. | Cerchia, C.

85

On the Metabolically Active Form of Metaglidasen: Improved Synthesis and Investigation of Its Peculiar Activity on Peroxisome Proliferator‐Activated Receptors and Skeletal Muscles

enthalten in: ChemMedChem | 2015

von Laghezza, A. | Montanari, R. | Lavecchia, A. | +11

86

Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor α/γ ligand LT175

enthalten in: European journal of medicinal chemistry | 2015

von Piemontese, L. | Fracchiolla, G. | Carrieri, A. | +11

87

Structural development studies of PPARs ligands based on tyrosine scaffold

enthalten in: European journal of medicinal chemistry | 2015

von De Filippis, B. | Linciano, P. | Ammazzalorso, A. | +9

88

5'-C-Ethyl-tetrazolyl-N(6)-substituted adenosine and 2-chloro-adenosine derivatives as highly potent dual acting A1 adenosine receptor agonists and A3 adenosine receptor antagonists

enthalten in: Journal of medicinal chemistry | 2015

von Petrelli, R. | Torquati, I. | Kachler, S. | +8

89

Therapeutic targeting the cell division cycle 25 (CDC25) phosphatases in human acute myeloid leukemia--the possibility to target several kinases through inhibition of the various CDC25 isoforms

enthalten in: Molecules (Basel, Switzerland) | 2014

von Brenner, A. | Reikvam, H. | Lavecchia, A. | +1

90

Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors

enthalten in: European journal of medicinal chemistry | 2014

von Troiano, V. | Scarbaci, K. | Ettari, R. | +8